StockData
NeoGenomics Inc logo

NeoGenomics Inc (NEO) stock

NEONasdaqServices-Testing LaboratoriesFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 11/3023% below fair value
$15.25−0.16 (-1.04%)

Close on Nov 17, 2026Market cap $1.97BP/E –Yield –

NeoGenomics ebitda

EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.

For fiscal 2020 it was $11.91M, down 64.3% from the year before. The highest annual figure on record is $33.35M in fiscal 2019.

Annual ebitda

PeriodPeriod endValueChange
FY2020Dec 31, 2020$11.91M-64.3%
FY2019Dec 31, 2019$33.35M+29.1%
FY2018Dec 31, 2018$25.84M+39.7%
FY2017Dec 31, 2017$18.50M+2.2%
FY2016Dec 31, 2016$18.09M+1552.2%
FY2015Dec 31, 2015$1.10M-85.5%
FY2014Dec 31, 2014$7.56M+2.7%
FY2013Dec 31, 2013$7.36M+51.9%
FY2012Dec 31, 2012$4.85M–

More NeoGenomics figures

See a number that looks wrong?